Avita Medical
RCEL
71 hedge funds and large institutions have $82.5M invested in Avita Medical in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 5 closing their positions.
380% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 5
189% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 9
188% more capital invested
Capital invested by funds: $28.6M → $82.5M (+$53.9M)
37% more funds holding
Funds holding: 52 → 71 (+19)
5.67% more ownership
Funds ownership: 17.63% → 23.3% (+5.7%)
3% more call options, than puts
Call options by funds: $449K | Put options by funds: $434K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$2.71M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.64M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$1.61M |
| 4 |
Jane Street
New York
|
+$1.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$968K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.44M |
| 2 |
Man Group
London,
United Kingdom
|
-$229K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$174K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$103K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$74K |
RCEL Hedge Fund Activity: Q1 2023 in Review
71 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2023, worth a combined $82.5M — up 188% from $28.6M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new RCEL positions and 5 closed out — a net gain of 19 holders — while 26 added to existing stakes and 9 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $2.71M. The largest seller was Pura Vida Investments, cutting an estimated $1.44M.
- 71 institutional investors held Avita Medical (RCEL) as of Q1 2023, up from 52 in Q4 2022.
- Funds reported $82.5M of Avita Medical stock for Q1 2023, up 188% quarter-over-quarter.
- 24 funds opened new Avita Medical positions in Q1 2023 and 5 closed out, a net change of +19 holders.
- The largest Avita Medical buyer in Q1 2023 was EAM Investors, an estimated $2.71M added.
- The largest Avita Medical seller in Q1 2023 was Pura Vida Investments, an estimated $1.44M sold.
Based on aggregated 13F filings for Q1 2023.